ALVO•globenewswire•
Alvotech Secures Term Loan Facility of USD 100 Million
Summary
REYKJAVIK, Iceland, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced a USD 100 million senior term loan facility with maturity in December 2027 aimed at strengthening liquidity and supporting the execution of Alvotech’s strategic priorities in 2026.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on December 31, 2025 by globenewswire